Overview
Subpulmonary stenosis, also known as infundibular pulmonary stenosis or subvalvular pulmonary stenosis, is a congenital heart defect characterized by narrowing (stenosis) of the right ventricular outflow tract below the pulmonary valve. This obstruction occurs in the infundibular region of the right ventricle, where muscular or fibrous tissue creates a barrier to blood flow from the right ventricle to the pulmonary artery. The condition primarily affects the cardiovascular system and can occur as an isolated defect or in association with other congenital heart malformations, most notably tetralogy of Fallot. Patients with subpulmonary stenosis may present with symptoms ranging from mild to severe depending on the degree of obstruction. Key clinical features include a cardiac murmur (typically a systolic ejection murmur heard at the left upper sternal border), exertional dyspnea (shortness of breath during physical activity), fatigue, and in severe cases, cyanosis (bluish discoloration of the skin due to reduced oxygen levels). Right ventricular hypertrophy may develop over time as the heart works harder to pump blood through the narrowed outflow tract. In neonates and infants with severe obstruction, symptoms may include failure to thrive and signs of right heart failure. Diagnosis is typically made through echocardiography, which can visualize the site and severity of the obstruction, supplemented by cardiac catheterization in some cases. Treatment depends on the severity of the stenosis. Mild cases may require only monitoring, while moderate to severe cases often necessitate surgical intervention. Surgical resection of the obstructing infundibular muscle or fibrous tissue is the primary treatment approach. In some cases, balloon dilation or placement of a transannular patch may be required. Outcomes following surgical correction are generally favorable, particularly when the condition is identified and treated early.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Subpulmonary stenosis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Subpulmonary stenosis at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Subpulmonary stenosis.
Community
No community posts yet. Be the first to share your experience with Subpulmonary stenosis.
Start the conversation →Latest news about Subpulmonary stenosis
No recent news articles for Subpulmonary stenosis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Subpulmonary stenosis
What is Subpulmonary stenosis?
Subpulmonary stenosis, also known as infundibular pulmonary stenosis or subvalvular pulmonary stenosis, is a congenital heart defect characterized by narrowing (stenosis) of the right ventricular outflow tract below the pulmonary valve. This obstruction occurs in the infundibular region of the right ventricle, where muscular or fibrous tissue creates a barrier to blood flow from the right ventricle to the pulmonary artery. The condition primarily affects the cardiovascular system and can occur as an isolated defect or in association with other congenital heart malformations, most notably tetra
At what age does Subpulmonary stenosis typically begin?
Typical onset of Subpulmonary stenosis is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Subpulmonary stenosis?
1 specialists and care centers treating Subpulmonary stenosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.